Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.69)
# 3,447
Out of 5,115 analysts
205
Total ratings
22.38%
Success rate
-7.1%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $0.95 | +846.67% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $2.80 | +7,042.86% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.84 | +225.34% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.01 | +296.04% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $1.99 | +0.50% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $4.29 | +4,562.00% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.10 | +804.76% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $1.17 | +1,694.87% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.00 | +1,403.46% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $2.50 | +22,300.00% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $2.91 | +4,023.71% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.33 | +445.70% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.71 | +1,654.39% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $8.85 | +114.81% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.20 | +627.27% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.87 | +588.86% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.74 | +13,411.69% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54,000 | $4.01 | +1,346,533.42% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.60 | +669.23% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.84 | +410,591.00% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $14.92 | +3,251.21% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $35.98 | +567.04% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.95 | +8,349.51% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $12.51 | +63,848.84% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.37 | +410.95% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.58 | +1,798.73% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.18 | +856.94% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $5.80 | +210.34% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.83 | +76.68% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $63.19 | -62.02% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.71 | +481,590.14% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.22 | +1,557,277.05% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $0.95
Upside: +846.67%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $2.80
Upside: +7,042.86%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.84
Upside: +225.34%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.01
Upside: +296.04%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.99
Upside: +0.50%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $4.29
Upside: +4,562.00%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.10
Upside: +804.76%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $1.17
Upside: +1,694.87%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.00
Upside: +1,403.46%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $2.50
Upside: +22,300.00%
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $2.91
Upside: +4,023.71%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $7.33
Upside: +445.70%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $1.71
Upside: +1,654.39%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.85
Upside: +114.81%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.20
Upside: +627.27%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.87
Upside: +588.86%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.74
Upside: +13,411.69%
Nov 12, 2024
Reiterates: Buy
Price Target: $54,000
Current: $4.01
Upside: +1,346,533.42%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.60
Upside: +669.23%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.84
Upside: +410,591.00%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $14.92
Upside: +3,251.21%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $35.98
Upside: +567.04%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.95
Upside: +8,349.51%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $12.51
Upside: +63,848.84%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.37
Upside: +410.95%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.58
Upside: +1,798.73%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.18
Upside: +856.94%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $5.80
Upside: +210.34%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $2.83
Upside: +76.68%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $63.19
Upside: -62.02%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.71
Upside: +481,590.14%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.22
Upside: +1,557,277.05%